Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph K Lim

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Clinical Liver Disease|December 15, 2020
Waking Up the Sleeping Giant: Treatment of Hepatitis B Reactivation During Immunosuppressive Drug TherapySaad Saffo, Joseph K Lim
Hepatology (Baltimore, Md.)|March 5, 2014
Advances in interferon-free hepatitis C therapy: 2014 and beyondSouvik Sarkar, Joseph K Lim
Hepatology (Baltimore, Md.)|March 10, 2023
Lean NAFLD is associated with adverse liver events and mortality: Moving beyond BMIAlbert Do, Joseph K Lim
Clinical Liver Disease|April 17, 2019
Hepatitis C Vaccine Development in the Era of Direct-Acting AntiviralsMatthew McConnell, Joseph K Lim
Journal of Clinical and Translational Hepatology|October 26, 2016
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug TherapyKohtaro Ooka, Joseph K Lim
Gastroenterology & Hepatology|December 6, 2019
Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug TherapyJessica Su, Joseph K Lim
Alimentary Pharmacology & Therapeutics|April 21, 2024
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practiceBasile Njei, Joseph K Lim
Clinical Liver Disease|May 9, 2024
Management of HBV reactivation: Challenges and opportunitiesCatherine Mezzacappa, Joseph K Lim
Hepatology (Baltimore, Md.)|June 8, 2013
Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infectionAnnMarie Liapakis, Joseph K Lim
World Journal of Hepatology|April 5, 2024
Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agentsRobert Lam, Joseph K Lim
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Clinical Liver Disease|December 15, 2020
Waking Up the Sleeping Giant: Treatment of Hepatitis B Reactivation During Immunosuppressive Drug TherapySaad Saffo, Joseph K Lim
Hepatology (Baltimore, Md.)|March 5, 2014
Advances in interferon-free hepatitis C therapy: 2014 and beyondSouvik Sarkar, Joseph K Lim
Hepatology (Baltimore, Md.)|March 10, 2023
Lean NAFLD is associated with adverse liver events and mortality: Moving beyond BMIAlbert Do, Joseph K Lim
Clinical Liver Disease|April 17, 2019
Hepatitis C Vaccine Development in the Era of Direct-Acting AntiviralsMatthew McConnell, Joseph K Lim
Journal of Clinical and Translational Hepatology|October 26, 2016
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug TherapyKohtaro Ooka, Joseph K Lim
Gastroenterology & Hepatology|December 6, 2019
Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug TherapyJessica Su, Joseph K Lim
Alimentary Pharmacology & Therapeutics|April 21, 2024
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practiceBasile Njei, Joseph K Lim
Clinical Liver Disease|May 9, 2024
Management of HBV reactivation: Challenges and opportunitiesCatherine Mezzacappa, Joseph K Lim
Hepatology (Baltimore, Md.)|June 8, 2013
Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infectionAnnMarie Liapakis, Joseph K Lim
World Journal of Hepatology|April 5, 2024
Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agentsRobert Lam, Joseph K Lim
Pageof 21